• Explore /
  • Poster
  • / Lipidomic profiling as a biomarker for prostate cancer diagnosis and response to enzalutamide (Enza).

Lipidomic profiling as a biomarker for prostate cancer diagnosis and response to enzalutamide (Enza).

Abstract Poster

Authors

null

Sara Bleve

IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy

Sara Bleve , Francesco Ravera , Silvia Rodrigues , Mohamed Omar , Emilio Francesco Giunta , Filippo Pederzoli , Hubert Pakula , Amelia Altavilla , Nicole Brighi , Giorgia Gurioli , Maria Concetta Cursano , Chiara Casadei , Cristian Lolli , Giuseppe Schepisi , David M. Nanus , Pier VItale Nuzzo , Ugo De Giorgi , Massimo Loda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 217)

DOI

10.1200/JCO.2024.42.4_suppl.217

Abstract #

217

Poster Bd #

K5

Abstract Disclosures

Similar Posters

First Author: Siyuan S Guo

First Author: Neeraj Agarwal

First Author: Jennifer Roberts

First Author: Xiaolin Zhu